Bellevue Asset Management (Switzerland)’s Teva Pharmaceuticals TEVA Stock Holding History

Bellevue Asset Management (Switzerland)’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	$11.6M	Buy	176,720 +7,500	+4%	+$463K	1.77%	14
2015 Q3	$9.55M	Buy	169,220 +2,270	+1%	+$147K	1.56%	15
2015 Q2	$9.87M	Buy	166,950 +26,950	+19%	+$1.66M	1.37%	22
2015 Q1	$8.72M	Buy	+140,000	New	+$8.14M	1.22%	29

Other funds holding TEVA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Bellevue Asset Management (Switzerland)'s TEVA Position: Q4 2015 in Review

Bellevue Asset Management (Switzerland) increased its Teva Pharmaceuticals (TEVA) stake by 4.4% in Q4 2015, buying an estimated $463K and bringing the position to 176,720 shares worth $11.6M. The position accounts for 1.77% of the portfolio, ranked #14.

Bellevue Asset Management (Switzerland) first reported a position in TEVA in Q1 2015 and has held it in 4 quarters since. 877 funds tracked by Wall St. Rank hold TEVA as of Q4 2015.

Bellevue Asset Management (Switzerland) held 176,720 shares of Teva Pharmaceuticals worth $11.6M as of Q4 2015.
Bellevue Asset Management (Switzerland) bought 7,500 Teva Pharmaceuticals shares in Q4 2015, an estimated $463K.
Teva Pharmaceuticals made up 1.77% of Bellevue Asset Management (Switzerland)'s portfolio in Q4 2015, its #14 holding.
Bellevue Asset Management (Switzerland) first reported a position in Teva Pharmaceuticals in Q1 2015 and has held it in 4 quarters since.
877 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2015.

Based on Bellevue Asset Management (Switzerland)'s 13F filing for Q4 2015, filed 12 Feb 2016.